T-CELL DIFFERENTIATION: MOLECULAR MECHANISMS
T-CELL DIFFERENTIATION: MOLECULAR MECHANISMS
批准号:
3166999
负责人:
EDWARD A BOYSE
金额:
$19.14万
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-09-30 至 1986-07-31
关键词:
B lymphocyte T lymphocyte autoimmune disorder autoradiography cell differentiation density gradient ultracentrifugation flow cytometry gel electrophoresis gene expression immunization immunodiffusion immunofluorescence technique immunogenetics immunoregulation membrane activity molecular biology monoclonal antibody murine leukemia virus nucleic acid inhibitor nucleotidyltransferase radioimmunoassay thymopoietin transforming virus
中文摘要
本文介绍了调节T细胞分化的各个方面和模型。
已解决。
有证据表明,某些T细胞淋巴瘤克隆是可诱导的,
在体外表达Lyt-1。Lyt-1表达的阻断和伴随的
Ly-5单克隆抗体产生的IL-2和其他数据提示我们,
前Lyl细胞上的Ly-5参与了IL-1依赖性步骤,
IL-2的产生和Lyl表型。 我们的目标是描述这一点
在转录和翻译方面的转变。
我们发现,重组γ-干扰素可以诱导Lyb-2,
继之以B谱系细胞的sIg表面表型。 一个特殊的点
有趣的是,这需要的γ-干扰素远少于
常规病毒保护(CPE)测定。 因此γ-干扰素可能
作为淋巴细胞分化剂,即使在
在普通CPE测定不能显示其存在的情况下。
Lyt-1在B细胞亚群中表达的意义以及Ly 1
而Ly 123组T细胞是模糊的。 我们的目标是阐明诱导
我们在有丝分裂原刺激的克隆性B细胞中观察到Lyt-1的增加,
与T细胞相比,转录和翻译方面。
描述的克隆Abelson淋巴瘤系产生主要的B
在培养物中表达Ly-5的220 K同种型的群体,但主要表达Ly-5的220 K同种型。
体内表达200 K同种型的T细胞群。 如果这个概念是正确的
原始转化细胞因此是祖细胞,
淋巴细胞,我们有一个有价值的模型,
(T与B),用于研究谱系相关亚型的调节
表情 我们的目标首先是确定替代路线
这些Abelson线采用的实际上符合正常的T和B
在Ly-5转录和翻译方面的谱系。
关于220 K(B-like)Ly-5产物的异常表达,
我们在lpr/lpr的扩增的Ly 1 T细胞群中观察到,
gld/gld小鼠淋巴细胞增殖综合征,我们的目的是解决
这个220 K是否与220 K亚型无法区分的问题
正常B细胞或增殖Ly 1细胞特有的产物,无论
增殖是正常还是不正常。 (LB)
英文摘要
Various aspects and models of the regulation of T-cell differentiation are
addressed.
Evidence is given that certain T-cell lymphoma clones are inducible to
express Lyt-1 in vitro. The blocking of Lyt-1 expression and accompanying
IL-2 production by Ly-5 monoclonal antibody, and other data, suggest to us
that Ly-5 on pre-Lyl cells is involved in the IL-1 dependent step leading
to IL-2 production and the Lyl phenotype. We aim to characterize this
transition in terms of transcription and translation.
We find that recombinant gamma-interferon can induce the Lyb-2 and
suceeding sIg surface phenotypes of B lineage cells. A point of special
interest is that this requires far less gamma-interferon than is needed in
conventional virus-protection (CPE) assay. Gamma-interferon may thus
deserve consideration as an agent of lymphocyte differentiation even in
circumstances where ordinary CPE assay does not reveal its presence.
The meaning of Lyt-1 expression by a sub-set of B cells as well as the Ly1
and Ly123 sets of T cells is obscure. We aim to elucidate the induced
augmentation of Lyt-1 we observe in mitogen-stimulated clonal B cells, in
terms of transcription and translation in comparison with T cells.
The clonal Abelson lymphoma lines described generate a predominant B
population expressing the 220K isoform of Ly-5 in culture but a predominant
T population expressing the 200K isoform in vivo. If the notion is correct
that the originating transformed cell was therefore the progenitor cell for
lymphocytes, we have a valuable model of alternative differentional options
(T versus B) with which to study the regulation of lineage-related isoform
expression. We aim first to determine whether the alternative routes
adopted by these Abelson lines in fact conform to the normal T and B
lineages in terms of Ly-5 transcription and translation.
With regard to the aberrant expression of a 220K (B-like) Ly-5 product
which we observe in the expanding Ly1 T cell population of lpr/lpr and
gld/gld mice with lympho-proliferative syndrome, we aim to settle the
question of whether this 220K is indistinguishable from the 220K isoforms
of normal B cells or a product peculiar to proliferating Ly1 cells, whether
that proliferation is normal or abnormal. (LB)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479140
-
项目类别:
-
资助金额:$87.85万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479141
-
项目类别:
-
资助金额:$53.38万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479136
-
项目类别:
-
资助金额:$87.38万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479139
-
项目类别:
-
资助金额:$90.05万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479138
-
项目类别:
-
资助金额:$37.47万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479135
-
项目类别:
-
资助金额:$11.5万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479142
-
项目类别:
-
资助金额:$54.01万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479137
-
项目类别:
-
资助金额:$95.02万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
NORMAL AND ABNORMAL CELL SURFACE GENETICS
-
批准号:3479133
-
项目类别:
-
资助金额:$47.91万
-
财政年份:1985
-
负责人:EDWARD A BOYSE
-
依托单位:
METHODS TO PREPARE ALLOANTISERA
-
批准号:3592964
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1981
-
负责人:EDWARD A BOYSE
-
依托单位:
METHODS TO PREPARE ALLOANTISERA
-
批准号:3592962
-
项目类别:
-
资助金额:$19.14万
-
财政年份:1981
-
负责人:EDWARD A BOYSE
-
依托单位:
METHODS TO PREPARE ALLOANTISERA
-
批准号:3592965
-
项目类别:
-
资助金额:$20.48万
-
财政年份:1981
-
负责人:EDWARD A BOYSE
-
依托单位:
IMMUNOGENETICS OF LY SYSTEMS
-
批准号:3165731
-
项目类别:
-
资助金额:$32.76万
-
财政年份:1977
-
负责人:EDWARD A BOYSE
-
依托单位:
T CELL DEVELOPMENT: IMMUNOGENETICS, DEFECTS, THERAPY
-
批准号:3165786
-
项目类别:
-
资助金额:$19.86万
-
财政年份:1977
-
负责人:EDWARD A BOYSE
-
依托单位:
海外基金